Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jun 03, 2018 10:25pm
314 Views
Post# 28118271

RE:RE:Now that Phase 1b is over and we have RTT :-)

RE:RE:Now that Phase 1b is over and we have RTT :-)
 
Ya laser!! Great!!! post!! Everybody getting money but us!!! Why???? Cancer treatments like ours a dime a dozen? 6 out of six not good enough?? No side affects not good enough?? One, two hr treatment to lengthy and strenuous???? 
Other pharmas have better results?? Nope they dont! They have similar results???? Nope they don't!!! We are unique and revolutionary and this MM cant find any partners, any deals , just horse doodoo so far!!! What the fuk do you expect from Roger, our business director!! The man with a plan, the man that won an academy award for his portrayal of a sphinx for over a year!!! The man that got into improv for the last year doing his Nero fiddling as TLT BURNED! Thats the guy working on deals!!! You got faith in him???? A OSC SMACKED LIAR WHO LOST HIS CEO SHIP FOR A SERIES OF MISTEPS THAT STILL STINK AND INFLUENCE OUR CREDIBILITY!!! Get that bum out!! Its a disgrace he is still on the board! 
Manny lets go!! Immediate future was months ago!!! U r starting to stink like Roger!!! Oh its going to be a fun AGM So many questions for the MM, MORONS IN MANAGEMENT!!!! 


.quote=LaserStock29]If we achieve one of these things i may show.... :-)   Hopefully we get a JV partner and do GBM for no.2 before the AGM.

That would be legit

LaserStock29 wrote: Brain and Lung Phase 1b are up next.

CBD for GBM... March 27/2018
Dr. Mandel stated, “I am very pleased with these preclinical results and if we are able to translate this technology successfully to humans, it strongly suggests that specific cannabinoids could be used to increase the efficacy of Theralase’s anti-cancer PDT technology in the destruction of deadly cancers, such as Glioblastoma Multiforme (“GBM”) brain cancer. The initial results reported are the first of a set of experiments planned by our scientific research team in the field of combining cannabinoids with Theralase’s PDT technology and also our anti-cancer vaccine, RuVaCare, in the destruction of human cancers. We believe this research will provide a strong foundation for a “first-in-man” clinical study, where the Company’s patented anti-cancer technology and / or anti-cancer vaccine will be combined with cannabinoid(s) in the treatment of cancer.Dr. Mandel concluded by saying that, “This latest preclinical research lays the groundwork for the Company to actively seek strategic partnerships in the co-development of this combined technology for the treatment of specific human cancers, such as GBM. The Company plans to explore these avenues in the immediate future, with the hopes of securing a joint venture with a company interested in the development of this combination technology, such as a Canadian cannabis producer.”

Rutherrin and NSCLC...March 5/2018
This research lays the ground work for further preclinical experiments to optimize the dose of Rutherrin® and laser light delivery strategy and if proven successful, the commencement of a Phase Ib clinical study for NSCLC, the leading cause of cancer related death.” 

(June 5th is 3 months for Lung and June 27th is 3 months for GBM) Personally i think the 1m PP was to fund the optimizations and development of Phase 1b plans for HC and FDA... 


So lets say that Sept 5th and 27th is 6 months to get it all handled.. 

That's end of summer we could verywell be headed into Late 2018 with Phase 2 and Phase 1b GBM Phase 1b NSCLC 

With a JV Canna partner.. 

Kinda that long wait --all of a sudden moments.


Yep...  Discover and DEVELOP deal....  lets get it.


Cambridge 2014 2:50-3:15

58m Preclin
58m Preclin
160m Phase 1

Upgrade

360m Phase 2 (can be higher cause no phase 3)
160m Phase 1 Brain
160m Phase 1 Lung

680m/169 = $4.02        Nab one of those big D&D deals and we're golden



User image

User image
 


[/quote]

Bullboard Posts